-
EP3485900
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3485900
| EP3485900 - ORAL DOSING OF GLP-1 COMPOUNDS [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 27.11.2020 Database last updated on 09.04.2026 | |
| Former | Request for examination was made Status updated on 05.12.2019 | ||
| Former | The application has been published Status updated on 19.04.2019 | Most recent event Tooltip | 11.03.2026 | New entry: Reply to examination report | Applicant(s) | For all designated states Novo Nordisk A/S Novo Allé 2880 Bagsværd / DK | [2019/21] | Inventor(s) | 01 /
NIELSEN, Flemming Seier Novo Nordisk A/S Novo Allé 2880 Bagsværd / DK | 02 /
SAUERBERG, Per Novo Nordisk A/S Novo Allé 2880 Bagsværd / DK | [2019/21] | Application number, filing date | 18188817.3 | 02.05.2014 | [2019/21] | Priority number, date | EP20130166205 | 02.05.2013 Original published format: EP 13166205 | [2019/21] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3485900 | Date: | 22.05.2019 | Language: | EN | [2019/21] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 20.02.2019 | Classification | IPC: | A61K38/26, A61P3/10, A61P3/04 | [2019/21] | CPC: |
A61K9/2013 (EP,US);
A61K38/26 (EP,KR,RU,US);
A61K31/166 (KR,US);
A61K9/0053 (KR,US);
A61K9/20 (KR);
A61P3/04 (EP,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/01] |
| Former [2019/21] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Title | German: | ORALE DOSIERUNG VON GLP-1-VERBINDUNGEN | [2019/21] | English: | ORAL DOSING OF GLP-1 COMPOUNDS | [2019/21] | French: | DOSAGE PAR VOIE ORALE DE COMPOSÉS GLP-1 | [2019/21] | Examination procedure | 21.11.2019 | Amendment by applicant (claims and/or description) | 22.11.2019 | Examination requested [2020/01] | 22.11.2019 | Date on which the examining division has become responsible | 30.11.2020 | Despatch of a communication from the examining division (Time limit: M09) | 10.09.2021 | Reply to a communication from the examining division | 02.09.2022 | Despatch of a communication from the examining division (Time limit: M04) | 19.12.2022 | Reply to a communication from the examining division | 17.05.2023 | Despatch of a communication from the examining division (Time limit: M04) | 26.09.2023 | Reply to a communication from the examining division | 22.05.2024 | Despatch of a communication from the examining division (Time limit: M06) | 22.11.2024 | Reply to a communication from the examining division | 13.01.2025 | Despatch of a communication from the examining division (Time limit: M06) | 30.07.2025 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time | 26.09.2025 | Reply to a communication from the examining division | 09.10.2025 | Despatch of a communication from the examining division (Time limit: M04) | 09.02.2026 | Reply to a communication from the examining division | 12.02.2026 | Despatch of a communication from the examining division (Time limit: M04) | 10.03.2026 | Reply to a communication from the examining division | Parent application(s) Tooltip | EP14721834.1 / EP2991671 | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 26.09.2025 | Request for further processing filed | 26.09.2025 | Full payment received (date of receipt of payment) Request granted | 06.10.2025 | Decision despatched | Fees paid | Renewal fee | 14.12.2018 | Renewal fee patent year 03 | 14.12.2018 | Renewal fee patent year 04 | 14.12.2018 | Renewal fee patent year 05 | 31.05.2019 | Renewal fee patent year 06 | 02.06.2020 | Renewal fee patent year 07 | 31.05.2021 | Renewal fee patent year 08 | 31.05.2022 | Renewal fee patent year 09 | 31.05.2023 | Renewal fee patent year 10 | 31.05.2024 | Renewal fee patent year 11 | 02.06.2025 | Renewal fee patent year 12 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y] WO2008033888 (SMITHKLINE BEECHAM CORP et al.) | [Y] US2013053311 (KALTHOFF CHRISTOPH et al.) | [Y] EP2565202 (SANWA KAGAKU KENKYUSHO CO et al.) | Examination | WO2013139694 | ANONYMOUS: "Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of a Long-acting GLP-1 Analogue in Healthy Male Subjects and Male Subjects With Type 2 Diabetes - Full Text View - ClinicalTrials.gov", 8 April 2013 (2013-04-08), XP93163609, Retrieved from the Internet | by applicant | WO2007024700 | WO2009030738 | WO9630036 | WO0046182 | WO0192206 | WO2008028859 | WO2007121318 | WO2006097537 | WO2011080103 | WO2008034881 | WO2009083549 | WO2010029159 | WO03072195 | EP2013055362 | EP2013055363 | JOHAN GABRIELSSON; DANIEL WEINER: "Concepts & Applications", 2000, SWEDISH PHARMACEUTICAL PRESS, article "Pharmacokinetics and Pharmacodynamic Data Analysis" | R. F. TAYLOR: "Protein immobilisation. Fundamental and applications", 1991, MARCEL DEKKER | S. S. WONG: "Chemistry of Protein Conjugation and Crosslinking", 1992, CRC PRESS | G. T. HERMANSON ET AL.: "Immobilized Affinity Ligand Techniques", 1993, ACADEMIC PRESS | ROWE ET AL.,: "Handbook of Pharmaceutical Excipients, 6th edition,", 2009, AMERICAN PHARMACEUTICALS ASSOCIATION AND THE PHARMACEUTICAL PRESS | GENNARO,: "Remington: the Science and Practice of Pharmacy, 21th edition,", 2005, LIPPINCOTT WILLIAMS & WILKINS | GREENE; WUTS: "Protective Groups in Organic Synthesis", 1999, JOHN WILEY & SONS |